<DOC>
	<DOCNO>NCT02855788</DOCNO>
	<brief_summary>phase II study weekly metronomic chemotherapy use weekly Paclitaxel , Oxaliplatin , Leucovorin 5-FU ( POLF ) patient advanced gastric cancer</brief_summary>
	<brief_title>Metronomic Chemotherapy Advanced Gastric Cancer</brief_title>
	<detailed_description>About 80 % patient advanced gastric cancer diagnose advanced stage limit treatment option include systemic chemotherapy without radiation . Commonly use maximally tolerate dose ( MTD ) chemotherapy DCT , ECF , FOLFOX regimens induce response range 20 50 % median survival range 10 12 month . Metronomic chemotherapy find consistent anti-tumor effect anti-angiogenic immunomodulating effect . Preliminary clinical study weekly POLF find encouraging clinical activity low overall toxicity pancreatic cancer gastric cancer . Here conduct formal clinical trial determine clinical efficacy side effect profile regimen patient advanced gastric cancer .</detailed_description>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1. pathologically confirm gastric cancer AJCC stage III IV 2. measurable disease base CT endoscopy exam 3. nonsurgical candidate patient decline surgery 4. nonradiation candidate patient decline radiation 5. patient able sign inform consent 6. patient 2 week recover surgery 7. patient complete radiation relieve obstructive symptom 8. patient previously receive Oxaliplatin 5FU MTD regimens 9. adequate marrow function : neutrophil &gt; 1000/ul , Hgb &gt; 10g/dl , Plt &gt; 50,000 1. allergic drug involve 2. concurrent malignancy 3. severe comorbidities heart , lung , kidney bone marrow 4. severe psychological disorder 5. severe malnutrition 6. difficult heal unhealed wound 7 . ECOG performance status equal 3 8. uncontrolled complication malignancy 9. uncontrolled CNS metastasis 10. peripheral neuropathy grade 3 11. pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>gastroesophageal cancer</keyword>
	<keyword>metastatic</keyword>
	<keyword>advanced</keyword>
</DOC>